Entering text into the input field will update the search result below

Prana Bio shows some life; shares up 44%

  • Thinly traded Prana Biotechnology (PRAN +44%) continues its up move on an impressive 29x surge in volume. Shares have rallied almost 70% since trading resumed Tuesday.
  • No particular news accounts for the action. It recently reported meeting with European regulators to clarify a path to a Phase 3 clinical trial for lead product candidate PBT2. It appears that it will need to conduct additional preclinical testing to assess safety issues before getting clearance to start human studies.
  • Previously: Prana Biotech not quite there for start of European late-stage study of lead product candidate in Huntington's (Dec. 23, 2016)

Recommended For You

About ATHE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ATHE--
Alterity Therapeutics Limited
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.